drug
Vfend
Marketedupdated 5mo agoby Greenstone LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6all catalysts(0)
nothing on the calendar yet
Trials studying Vfend
- phase2Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
- phase1Study on the Drug Interaction Between Buagafuran and Voriconazole
- phase1A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants
- phase1Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
- phase3Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
- phase3Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
- phase2Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- phase1Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that